- $416.08m
- $421.58m
- $824.50m
Brief: New Meta-Analysis Demonstrates That Access To The Genesight Test Can Significantly Improve Response And Remission Rates For Patients With Depression
Brief: Myriad Genetics Appoints Ben Wheeler Chief Financial Officer
Myriad Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Myriad Genetics Q2 EPS USD -3.57
Brief: Myriad Genetics Announces New $200 Million Credit Facility
U.S. RESEARCH ROUNDUP-Levi Strauss, Myriad Genetics, Palo Alto
Myriad Genetics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Myriad Genetics Q1 Operating Income USD -29 Million
Brief: Myriad Genetics Names Brian Donnelly As New Chief Commercial Officer
U.S. STOCKS ON THE MOVE-HubSpot, Casey's General Stores, ANI Pharma
U.S. STOCKS ON THE MOVE-Corvus, Dogwood Therapeutics, Uranium Energy
U.S. STOCKS ON THE MOVE-Intel, Groupon, Stitch Fix
Piper Sandler upgrades Myriad to 'overweight' on CEO change
Brief: Myriad Genetics And Gabbi To Work Together To Increase Access To Hereditary Cancer Risk Assessment Tools
U.S. RESEARCH ROUNDUP-Domino's Pizza, Owens Corning, Ventas
Myriad Genetics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Myriad Genetics Appoints Sam Raha As President And CEO
Brief: Myriad Genetics Announces Two New Patents Granted For Its Molecular Residual Disease (MRD) Assay
U.S. STOCKS ON THE MOVE-Wolfspeed, Netflix, Spotify